Alessandro Pirosa

Alessandro Pirosa

Auto-generated profile, based on publicly available information

Alessandro Pirosa

Center for Cellular and Molecular Engineering, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; BIOlab Research Group, Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2018 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
APAlessandro Pirosa
Alessandro Pirosa
RGRiccardo Gottardi
Riccardo Gottardi
PAPeter G Alexander
Peter G Alexander
RTRocky S. Tuan
Rocky S. Tuan
The production of veritable in-vitro models of bone tissue is essential to understand the biology of bone and its surrounding environment, to analyze the pathogenesis of bone diseases (e.g., osteoporosis, osteoarthritis, osteomyelitis, etc.), to develop effective therapeutic drug screening, and to test potential therapeutic strategies. Dysregulated interactions between vasculature and bone cells are often related to the aforementioned pathologies, underscoring the need for a bone model that contains engineered vasculature. Due to ethical restraints and limited prediction power of animal models, human stem cell-based tissue engineering has gained increasing relevance as a candidate approach to overcome the limitations of animals and to serve as preclinical models for drug testing. Since bone is a highly vascularized tissue, the concomitant development of vasculature and mineralized matrix requires a synergistic interaction between osteogenic and endothelial precursors. A number of experimental approaches have been used to achieve this goal, such as the combination of angiogenic factors and three-dimensional scaffolds, prevascularization strategies, and coculture systems. In this review, we present an overview of the current models and approaches to generate in-vitro stem cell-based vascularized bone, with emphasis on the main challenges of vasculature engineering. These challenges are related to the choice of biomaterials, scaffold fabrication techniques, and cells, as well as the type of culturing conditions required, and specifically the application of dynamic culture systems using bioreactors.

1 May 2021 in Biomaterials
Verified
Journal Article
Closed access
APAlessandro Pirosa
Alessandro Pirosa
RGRiccardo Gottardi
Riccardo Gottardi
PAPeter G Alexander
Peter G Alexander
Dario PuppiDario Puppi
Dario Puppi
Federica ChielliniFederica Chiellini
Federica Chiellini
RTRocky S. Tuan
Rocky S. Tuan

12 January 2016 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
Dario PuppiDario Puppi
Dario Puppi
Anna Maria PirasAnna Maria Piras
Anna Maria Piras
APAlessandro Pirosa
Alessandro Pirosa
SSStefania Sandreschi
Stefania Sandreschi
Federica ChielliniFederica Chiellini
Federica Chiellini

4 March 2016 in Polymer International
Verified
Journal Article
Closed access
PDF file
Dario PuppiDario Puppi
Dario Puppi
CMChiara Migone
Chiara Migone
LGLucia Grassi
Lucia Grassi
APAlessandro Pirosa
Alessandro Pirosa
GMGiuseppantonio Maisetta
Giuseppantonio Maisetta
Federica ChielliniFederica Chiellini
Federica Chiellini

7 June 2017 in Biomedical Materials
Verified
Journal Article
Closed access
PDF file
Dario PuppiDario Puppi
Dario Puppi
APA Pirosa
A Pirosa
GLG Lupi
G Lupi
PEP A Erba
P A Erba
GGG Giachi
G Giachi
Federica ChielliniFederica Chiellini
Federica Chiellini
Biodegradable stents have emerged as one of the most promising approaches in obstructive cardiovascular disease treatment due to their potential in providing mechanical support while it is needed and then leaving behind only the healed natural vessel. The aim of this study was to develop polymeric biodegradable stents for application in small caliber blood vessels. Poly[(R)-3-hydroxybutyrate-co-(R)-3-hydroxyhexanoate] (PHBHHx), a renewable microbial aliphatic polyester, and poly( ε -caprolactone), a synthetic polyester approved by the US Food and Drug Administration for different biomedical applications, were investigated as suitable polymers for stent development. A novel manufacturing approach based on computer-aided wet-spinning of a polymeric solution was developed to fabricate polymeric stents. By tuning the fabrication parameters, it was possible to develop stents with different morphological characteristics (e.g. pore size and wall thickness). Thermal analysis results suggested that material processing did not cause changes in the molecular structure of the polymers. PHBHHx stents demonstrated great radial elasticity while PCL stents showed higher axial and radial mechanical strength. The developed stents resulted able to sustain proliferation of human umbilical vein endothelial cells within two weeks of in vitro culture and they showed excellent results in terms of thromboresistivity when in contact with human blood.

10 August 2015 in Journal of Bioactive and Compatible Polymers
Verified
Journal Article
Open access
FDFrancesca Dini
Francesca Dini
GBGiovanni Barsotti
Giovanni Barsotti
Dario PuppiDario Puppi
Dario Puppi
ACAlessandra Coli
Alessandra Coli
ABAngela Briganti
Angela Briganti
Federica ChielliniFederica Chiellini
Federica Chiellini
One of the most challenging requirements of a successful bone tissue engineering approach is the development of scaffolds specifically tailored to individual tissue defects. Besides materials chemistry, well-defined scaffold’s structural features at the micro- and macro-levels are needed for optimal bone in-growth. In this study, polymeric fibrous scaffolds with a controlled internal network of pores and modelled on the anatomical shape and dimensions of a critical size bone defect in a rabbit’s radius model were developed by employing a computer-aided wet-spinning technique. The tailored scaffolds made of star poly(ε-caprolactone) or star poly(ε-caprolactone)–hydroxyapatite composite material were implanted into 20-mm segmental defects created in radial diaphysis of New Zealand white rabbits. Bone regeneration and tissue response were assessed by X-rays and histological analysis at 4, 8 and 12 weeks after surgery. No signs of macroscopic and microscopic inflammatory reactions were detected, and the developed scaffolds showed a good ability to support and promote the bone regeneration process. However, no significant differences in osteoconductivity were observed between star poly(ε-caprolactone) and star poly(ε-caprolactone)–hydroxyapatite scaffolds. Long-term study on implanted star poly(ε-caprolactone) scaffolds confirmed the presence of signs of bone regeneration and remodelling, particularly evident at 24 weeks.